Precigen Inc. (PGEN) Fundamentals

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
SHARE INFORMATION
Market Cap$ 501,641,551
Shares Outstanding208,150,021
Float121,049,365
Percent Float58.15%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 103,873,000
Latest Fiscal EPS$ -0.47
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions330
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months12,446,141
Institutional Holdings Percent86.0%
Institutional Sold Previous 3 Months22,636,632
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months417,426
Insider Holdings Percent2.4
Insider Sold Previous 3 Months631,087
Insider Shares Owned4,889,927
TRADING INFO
52 Week High$ 6.46
52 Week Low$ 1.12
52 Week High Change$ -58.80
21 Day Moving Average$ 1.9781
21 Day Extended Moving Average$ 2.0471
50 Day Moving Average$ 1.6742
50 Day Extended Moving Average$ 1.8137
200 Day Moving Average$ 2.4142
200 Day Extended Moving Average$ 2.5502
10 Day Average Volume1,439,137
20 Day Average Volume1,250,325
30 Day Average Volume1,440,031
50 Day Average Volume1,747,839
Alpha-0.033787
Beta2.2801
Standard Deviation0.280213
R20.165628
7 Day Price Change$ 0.10
7 Day Percent Change4.33%
21 Day Price Change$ 0.61
21 Day Percent Change33.89%
30 Day Price Change$ 0.72
30 Day Percent Change42.6%
Month to Date Price Change$ 0.84
Month to Date Percent Change53.5%
Quarter to Date Price Change$ 1.07
Quarter to Date Percent Change79.85%
180 Day Price Change$ 0.25
180 Day Percent Change11.57%
200 Day Price Change$ -0.05
200 Day Percent Change-2.03%
Year to Date Price Change$ -1.30
Year to Date Percent Change-35.04%

Precigen Inc. (PGEN) Key Ratios

PROFITABILITY
EBIT Margin-71.7%
EBITDA Margin-59.1%
Pre-Tax Profit Margin-156.6%
Profit Margin Count-94.2%
Gross Margin43.5%
Profit Margin TOT-93.9%
INCOME STATEMENTS
Revenue$ 80,714,000
Revenue Per Share$ 0.3878
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-20.10
Total Debt To Equity3.70
Int Coverage-5.40
Current Ratio5.50
Leverage Ratio3.80
Quick Ratio3.90
Long Term Debt To Capital0.79
VALUATION MEASURES
PE Ratio-5.60
Enterprise Value$ 637,861,055
Price to Sales6.2151
Price to Free Cash-8.30
PE High Last 5 Years-2.30
Price To Book9.80
Price To Cash Flow61.50
PE Low Last 5 Years-6.50
Price to Tangible Book-20.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.90
Invoice Turnover11.50
Assets Turnover0.30
Return Assets-27.09
Return on Equity-93.40
Return on Capital-25.90

Precigen Inc. (PGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOHelen Sabzevari
Emplyoees320
Last AuditUE
CIK0001356090
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address20374 Seneca Meadows Parkway
Germantown, MD 20876
Websitehttp://www.precigen.com
Facsimile-
Telephone+1 301 556-9900
Emailinvestors@precigen.com


Your Recent History
NASDAQ
PGEN
Precigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.